Vinny ..here is a reference to the recent Japan delegation.
http://www.copyright link/business/...ng-with-australian-technology-20170425-gvrpo9
..."Having missed the earlier antibody revolution (mainly around cancer drugs), Japan is betting big that regenerative medicine is the way of the future "...
As aGVHD is currently available via JCR, in my view Japan will be looking to the next most advanced MSB application.
So I'll be keeping an eye out to see what happens with Revascor - particularly in view of the recent green light by the IDMC.
GLTAH.
Japan as a Funding Source, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.030(2.63%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.11 | $4.446M | 3.889M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12008 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 35718 | 14 |
View Market Depth
| Last trade - 11.47am 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |